10,076 Shares in The Cooper Companies, Inc. $COO Acquired by Landscape Capital Management L.L.C.

Key Points

• Landscape Capital Management L.L.C. acquired 10,076 shares of The Cooper Companies, Inc. (NASDAQ:COO) valued at approximately $850,000 during the first quarter.
• Analysts have recently adjusted their price targets, with Wells Fargo reducing their target from $93.00 to $72.00 and BNP Paribas upgrading their rating to a strong-buy.
• The Cooper Companies reported earnings of $1.10 EPS for the last quarter, surpassing estimates, and provided guidance for Q4 2025 at 1.100-1.140 EPS.

Landscape Capital Management L.L.C. bought a new position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 10,076 shares of the medical device company's stock, valued at approximately $850,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Zions Bancorporation National Association UT bought a new stake in shares of Cooper Companies in the 1st quarter worth approximately $33,000. City Holding Co. bought a new stake in shares of Cooper Companies in the 1st quarter worth approximately $34,000. GKV Capital Management Co. Inc. bought a new stake in shares of Cooper Companies in the 1st quarter worth approximately $40,000. Larson Financial Group LLC raised its holdings in shares of Cooper Companies by 1,071.0% in the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after purchasing an additional 664 shares in the last quarter. Finally, HM Payson & Co. raised its holdings in shares of Cooper Companies by 147.4% in the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after purchasing an additional 532 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. Wells Fargo & Company dropped their target price on shares of Cooper Companies from $93.00 to $72.00 and set an "overweight" rating on the stock in a report on Thursday. Piper Sandler cut their price target on shares of Cooper Companies from $105.00 to $83.00 and set an "overweight" rating on the stock in a report on Thursday. Needham & Company LLC restated a "buy" rating and set a $94.00 price target on shares of Cooper Companies in a report on Thursday. JPMorgan Chase & Co. cut their price target on shares of Cooper Companies from $76.00 to $66.00 and set a "neutral" rating on the stock in a report on Thursday. Finally, BNP Paribas upgraded shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $86.64.

Cooper Companies Stock Up 4.4%

COO stock opened at $67.39 on Friday. The company's 50 day simple moving average is $72.29 and its 200-day simple moving average is $77.40. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $112.38. The firm has a market capitalization of $13.48 billion, a P/E ratio of 33.20, a P/E/G ratio of 1.63 and a beta of 1.00. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.23.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating analysts' consensus estimates of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the previous year, the firm posted $0.96 earnings per share. The firm's revenue was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.